YOLFTbeta
RTW Venture Fund Ltd

RTW Venture Fund Ltd

RTW · LSE · Financial Services / Asset Management

2.44USD-0.04 (-1.61%)

Price History

Full chart

Market Stats

Previous Close2.48
Open2.51
Day Range2.44 – 2.51
52-Week Range1.55 – 2.64
Volume534.32K
Market Cap754.68M
P/E (TTM)0.02
Forward P/E0.00
EPS1.28
Dividend Yield0.00%
Beta0.77
50-Day Avg2.45
200-Day Avg2.24

About

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

Company Details

Leadership

  • Baroness Nicola BlackwoodSenior Independent Non-Executive Director · b. 1979
  • Ms. Krisha McCuneDirector of Investor Relations
  • Dr. Roderick Tze Ian Wong M.B.A., M.D.Investment Professional · b. 1977
  • Mr. Woody StilemanInvestment Professional

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue27.99M39.71M162.77M-60.92M-36.51M87.86M43.50M258.01M
Growth (%)-+41.86%+309.90%-137.43%+40.07%+340.64%-50.49%+493.12%
Cost of Revenue70.62K1.31M4.58M215.61K3.75M4.27M4.77M7.13M
Gross Profit27.99M39.71M162.77M-60.92M-36.51M67.02M38.73M250.89M
Gross Margin100.00%100.00%100.00%100.00%100.00%76.28%89.03%97.24%
Operating Expense71.00K992.71K2.12M3.43M2.15M70.01M-162.00K5.69M
Operating Income27.92M38.72M160.65M-64.34M-38.66M-2.99M38.89M245.19M
Operating Margin99.75%97.50%98.70%105.62%105.88%-3.40%89.40%95.03%
EBITDA27.92M38.72M160.65M-64.34M-38.66M84.75M38.89M245.19M
EBITDA Margin99.75%97.50%98.70%105.62%105.88%96.47%89.40%95.03%
Net Income27.92M38.72M160.65M-64.34M-39.44M83.19M34.18M245.19M
Net Income Margin99.75%97.50%98.70%105.62%108.02%94.69%78.57%95.03%
R&D6.42K97.97K130.49K237.98K742.74K474.51K849.45K-
R&D as % of Total Revenue0.02%0.25%0.08%-0.39%-2.03%0.54%1.95%-
Interest Expense017.48K73.55K215.61K779.99K1.56M4.77M7.13M
Interest Expense % of Total Revenue0.00%0.04%0.05%-0.35%-2.14%1.78%10.97%2.76%

Balance Sheet

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.82M65.76M215.80M420.90M439.36M401.54M446.23M760.02M1.07B
Total Liabilities23.05K32.24K1.41M8.29M52.00M53.62M17.21M127.37M203.82M
Total Equity37.80M65.72M214.39M412.61M387.36M326.08M399.28M606.92M800.88M
Cash75.61K31.32K10.73M4.55M6.48M6.97M2.72M5.36M5.99M
Total Debt--202.93K6.67M-12.44M1.20M95.15M160.55M
Net Debt--31.32K-10.53M2.12M-6.48M5.47M-2.72M-5.36M154.57M

Cash Flow

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-11.71M-44.28K-66.16M-10.84M-44.87M-15.67M33.54M-124.34M54.20M
Investing Cash Flow---66.03M-46.31M-26.03M--51.05M
Financing Cash Flow11.79M109.95M109.95M37.57M39.09M--2.09M97.08M-12.61M
Capital Expenditure00040037.32M38.52M5
Free Cash Flow--44.28K-66.16M-57.14M-44.87M10.35M70.86M-124.34M54.20M
Dividends Paid---4.15M4.97M0---
FCF to OCF-100.00%100.00%527.30%100.00%-66.07%211.28%100.00%100.00%
Dividend Paid to FCF----7.26%-11.09%0.00%---

Earnings

Report DateSep 24, 2020Apr 29, 2021Sep 16, 2021Mar 31, 2022Sep 15, 2022Mar 31, 2025Sep 11, 2025
EPS Estimate0.00--0.00-0.00-
EPS Actual0.060.73-0.09-0.21-0.49-0.15-0.12
Surprise-------
Timing---Pre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap754.68M
Enterprise Value843.78M
Trailing P/E0.02
Forward P/E0.00
Price / Sales55.72
Price / Book0.75
EPS1.28
Book Value2.86
Revenue (TTM)13.54M
Gross Profit (TTM)13.54M
Profit Margin3360.46%
Operating Margin12.17%
Return on Equity57.00%
Return on Assets-0.06%
Shares Outstanding321.14M
Shares Float0
Beta0.77
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%